MicroRNA changes in rat mesentery and serum associated with drug-induced vascular injury

Toxicology and Applied Pharmacology

Volumn 262, Issue 3, 2012, Pages 310-320

  Thomas, Roberta A ^a   Scicchitano, Marshall S ^a   Mirabile, Rosanna C ^a   Chau, Nancy T ^a   Frazier, Kendall S ^a   Thomas, Heath C ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Dopamine; Drug induced vascular injury; Fenoldopam; Mesentery; MicroRNA; Serum

Indexed keywords

DOPAMINE; FENOLDOPAM; MICRORNA; MICRORNA 100; MICRORNA 107; MICRORNA 10B; MICRORNA 122; MICRORNA 132; MICRORNA 134; MICRORNA 141; MICRORNA 155; MICRORNA 15A; MICRORNA 15B; MIDODRINE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; HEMODYNAMICS; IN SITU HYBRIDIZATION; MALE; MESENTERY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD VESSELS; DOPAMINE; FENOLDOPAM; HEMODYNAMICS; IN SITU HYBRIDIZATION; MALE; MESENTERY; MICRORNAS; MIDODRINE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84863819618     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.05.009     Document Type: Article

References (61)

1. Anand S., Majeti B.K., Acevedo L.M., Murphy E.A., Mukthavaram R., Scheppke L., Huang M., Shields D.J., Lindquist J.N., Lapinski P.E., King P.D., Weis S.M., Cheresh D.A. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med. 2010, 16(8):909-914.
2. Behrecke E.H. miRNAs: micro managers of programmed cell death. Curr. Biol. 2003, 13. R473-5.
3. Bostjancic E., Zidar N., Stajer D., Glavac D. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 2010, 115(3):163-169.
4. Brott D., Gould S., Jones H., Schofield J., Prior H., Valentin J.P., Bjurstrom S., Kenne K., Schuppe-Koistinen I., Katein A., Foster-Brown L., Betton G., Richardson R., Evans G., Louden C. Biomarkers of drug-induced vascular injury. Toxicol. Appl. Pharmacol. 2005, 207(2 Suppl.):441-445.
5. Caporali A., Meloni M., Völlenkle C., Bonci D., Sala-Newby G.B., Addis R., Spinetti G., Losa S., Masson R., Baker A.H., Agami R., le Sage C., Condorelli G., Madeddu P., Martelli F., Emanueli C. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 2011, 123(3):282-291.
6. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Siang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Want J., Zen K., Zhang J., Zhang C. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18:997-1006.
7. Chim S.S.C., Shing T.K.F., Hung E.C.W., Leung T., Lau T., Chiu R.W.K., Lo Y.M.D. Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem. 2008, 53(3):482-490.
8. Choudhuri S. Small noncoding RNAs: biogenesis, function, and emerging significance in toxicology. J. Biochem. Mol. Toxicol. 2010, 24(3):195-215.
9. D'Alessandra Y., Pompilio G., Capogrossi M.C. Letter by D'Alessandra et al regarding article, "circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease". Circ. Cardiovasc. Genet. 2011, 4(1):e7. (Feb, author reply e8).
10. Dalmas D.A., Scicchitano M.S., Chen Y., Kane J., Mirabile M., Schwartz L.W., Thomas H.C., Boyce R.W. Transcriptional profiling of laser capture microdissected rat arterial elements: fenoldopam-induced vascular toxicity as a model system. Toxicol. Pathol. 2008, 36:496-519.
11. Dalmas D.A., Scicchitano M.S., Mullins D., Hughes-Earle A., Tatsuoka K., Magid-Slav M., Frazier K.S., Thomas H.C. Potential candidate genomic biomarkers of drug induced vascular injury in the rat. Toxicol. Appl. Pharmacol. 2011, (Epub ahead of print). 10.1016/j.taap. 2011.09.015.
12. Di Stefano V., Zaccagnini G., Capogrossi M.C., Martelli F. microRNAs as peripheral blood biomarkers of cardiovascular disease. Vascul. Pharmacol. 2011, 55(4):111-118.
13. Estep M., Armistead D., Hossain N., Elarainy H., Goodman Z., Baranova A., Chandhoke V., Younossi Z.M. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2010, 32(3):487-497.
14. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., Weber M., Hamm C.W., Röxe T., Müller-Ardogan M., Bonauer A., Zeiher A.M., Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 2010, 107(5):677-684.
15. Gao J., Wang W.Y., Mao Y.W., Gräff J., Guan J.S., Pan L., Mak G., Kim D., Su S.C., Tsai L.H. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010, 466:1105-1109.
16. Gilad S., Meiri E., Yogen Y., Benjamin S., Lebanony D., Yerushalmi N., Benjamin H., Kushner M., Cholakh H., Melamed N., Bentwich Z., Hod M., Goren Y., Chajut A. Serum microRNAs are promising novel biomarkers. PLoS One 2008, 3(9):e3148.
17. Gollasch M. Vasodilator signals from perivascular adipose tissue. Br. J. Pharmacol. 2011, (Epub ahead of print). 10.1111/j.1476-5381.2011.01430.x.
18. Gollasch M., Dubrovska G. Paracrine role for periadventitial adipose tissue in the regulation of arterial tone. Trends Pharmacol. Sci. 2004, (12):647-653.
19. Hartmann D., Thum T. MicroRNAs and vascular (dys)function. Vascul. Pharmacol. 2011, 55(4):92-105. (Oct).
20. He Z., Kokkinanki M., Pant D., Galliano G.I., Dym M. Small RNA molecules in the regulation of spermatogenesis. Reproduction 2009, 137:901-911.
21. Hoekstra M., van der Lans C.A.C., Halvorsen B., Gullestad L., Kuiper J., Aukrust P., van Berkel T.J.C., Biessen E.A.L. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem. Biophys. Res. Commun. 2010, 394:792-797.
22. Holford N.C., Sandhu H.S., Thakkar H., Butt A.N., Swaminathan R. Stability of β-actin mRNA in plasma. Ann. N. Y. Acad. Sci. 2008, 1137:108-111.
23. Hua Z., Lv Q., Ye W., Wong C.K., Cai G., Gu D., Ji Y., Zhao C., Wang J., Yang B.B., Zhang Y. miRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 2006, 1:e116. (Dec 27).
24. Jiang Y., Yin H., Zheng X.L. MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells. J. Cell. Physiol. 2010, 225(2):506-511.
25. Jung M., Schaefer A., Steiner I., Kempkensteffen C., Stephan C., Erbersdobler A., Jung K. Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin. Chem. 2010, 56(6):998-1006.
26. Katare R., Riu F., Mitchell K., Gubernator M., Campagnolo P., Cui Y., Fortunato O., Avolio E., Cesselli D., Beltrami A.P., Angelini G., Emanueli C., Madeddu P. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ. Res. 2011, 109(8):894-906.
27. Kermani P., Hempstead B. Brain-derived neurotriphic factor: a newly described mediator of angiogenesis. Trends Cardiovasc. Med. 2007, 17(4):140-143.
28. Kerns W.D., Arena A., Morgan D.G. Role of DMrgic and adrenergic receptors in the pathogenesis of arterial lesions induced by fendoldopam mesylate and dopamine in the rat. Am. J. Pathol. 1989, 135(2):339-349.
29. Knapton A.D., Zhang F.D., Sistare F.D., Haning J.P. The use of in situ perfusion of the rat mesentery as a model to investigate vascular injury directly induced by drugs. Methods Find. Exp. Clin. Pharmacol. 2010, 32(7):489-497.
30. Kogame M., Matsuo S., Nakatani M., Kurisaki A., Nishitani H., Tsuchida K., Sugino H. ALK7 is a novel marker for adipocyte differentiation. J. Med. Invest. 2006, 53(3-4):238-245.
31. Krichevsky A.M., King K.S., Donahue C.P., Khrapko K., Kosik K.S. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 2003, 9:1274-1281.
32. Laterza O.F., Lim L., Garrett-Engele P.W., Vlasakova K., Muniappa N., Tanaka W.K., Johnson J.M., Sina J.F., Fare T.L., Sistare F.D., Glaab W.E. Plasma microRNAs as diagnostically sensitive and specific biomarkers of tissue injury. Clin. Chem. 2009, 55(11):1977-1983.
33. Liu G., Huang Y., Lu X., Lu M., Huang X., Li W., Jiang M. Identification and characteristics of microRNAs with altered expression patterns in a rat model of abdominal aortic aneurysms. Tohoku J. Exp. Med. 2010, 222(3):187-193.
34. Louden C., Brott D., Katein A., Kelly T., Gould S., Jones H., Betton G., Valetin J., Richardson R.J. Biomarkers and mechanisms of drug-induced vascular injury in non-rodents. Toxicol. Pathol. 2006, 34:19-26.
35. Luo S.S., Ishibashi O., Ishikawa G., Ishikawa T., Katayama A., Mishima T., Takizawa T., Shigihara T., Goto T., Izumi A., Ohkuchi A., Matsubara S., Takeshita T., Takizawa T. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol. Reprod. 2009, 81(4):717-729.
36. Mestdagh P., VanVlierbergh P., De Weer A., Muth D., Westermann F., Speleman F., Vandesompele J. A novels and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009, 10:R64.
37. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentelman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. PNAS 2008, 105(30):10513-10518.
38. Molnár V., Érsek B., Wiener Z., Hegyi K., Falus A. MicroRNA-132 targets HB-EGF upon IgE-mediated activation in murine and human mast cells. Oxford J. Life Sci. Med. Intimm. Meeting Abstracts 2010, 22(Suppl. 1 Pt 1):i132-i134.
39. Mraz M., Pospisilova S., Malinova K., Slapak I., Mayer J. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk. Lymphoma 2009, 50(3):506-509.
40. National Research Council Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, DC.
41. Newsholme S.J., Thudium D.T., Gossett K.A., Watson E.S., Schwartz L.W. Evaluation of plasma von willebrand factor as a biomarker for acute arterial damage in rats. Toxicol. Pathol. 2000, 28(5):688-693.
42. Patnaik S.K., Mallick R., Yendamuri S. Detection of microRNAs in dried serum blots. Anal. Biochem. 2010, 10.1016/j.ab.2010.08.004.
43. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., Mercatanti A., Hammond S., Rainaldi G. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006, 108(9):3068-3071.
44. Ricci A., Amenta F., Bronzetti E., Felici L., Hussain T., Mokhandwala M.F. Age-related changes of dopamine receptor protein immunoreactivity in the rat mesenteric vascular tree. Mech. Ageing Dev. 2002, 123:537-546.
45. Rippe C., Blimline M., Magerko K.A., Lawson B.R., Larocca T., Donato A.J., Seals D.R. MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation. Exp. Gerontol. 2011, (Epub ahead of print). 10.1016/j.exger.2011.10.004.
46. Santoro M.M. "Fishing" for endothelial microRNA functions and dysfunction. Vascul. Pharmacol. 2011, 55(4):60-68. (Oct).
47. Saunders M.A., Lim L.P. (Micro)genomic medicine. RNA Biol. 2009, 6(3):324-328.
48. Schauer I.E., Knaub L.A., Lloyd M., Watson P.A., Gliwa C., Lewis K.E., Chait A., Klemm D.J., Gunter J.M., Bouchard R., McDonald T.O., O'Brien K.D., Reusch J.E. CREB downregulation in vascular disease: a common response to cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 2010, 30(4):733-741.
49. Sen C.K., Gordillo G.M., Khanna S., Roy S. Micromanaging vascular biology: tiny microRNAs play big band. J. Vasc. Res. 2009, 46(6):527-540.
50. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469(7330):336-342.
51. Thomas R.A., Pietrzak D.C., Scicchitano M.S., Thomas H.C., McFarland D.C., Frazier K.S. Detection and characterization of circulating endothelial progenitor cells in normal rat blood. J. Pharmacol. Toxicol. Methods 2009, 60(3):263-274.
52. Ugras S., Brill E., Jacobsen A., Hafner M., Socci N.D., Decarolis P.L., Khanin R., O'Connor R., Mihailovic A., Taylor B.S., Sheridan R., Gimble J.M., Viale A., Crago A., Antonescu C.R., Sander C., Tuschl T., Singer S. Small RNA sequencing and functional characterization reveals microRNA-143 tumor suppressor activity in liposarcoma. Cancer Res. 2011, 71(17):5659-5669.
53. Urbich C., Kuehbacher A., Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. 2008, 79(4):581-588.
54. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9(6):654-659.
55. van Rooij E., Sutherland L.B., Thatcher J.E., DiMaio J.M., Naseem R.H., Marshall W.S., Hill J.A., Olson E.N. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(35):13027-13032.
56. Verlohren S., Dubrovska G., Tsang S.Y., Essin K., Luft F.C., Huang Y., Gollasch M. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004, 44(3):271-276.
57. Wang K., Zhang S., Marzolk B., Troisch P., Brighmand A., Hu Z., Hood L.E., Galas D.J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. PNAS 2008, 106(11):4402-4407.
58. Wang K., Zhang S., Weber J., Baxter D., Galas D.J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010, 38(20):7248-7259.
59. Weaver J.L., Zhang J., Knapton A., Miller T., Espandiari P., Smith R., Gu Y.Z., Snyder R.D. Early events in vascular injury in the rat induced by the phosphodiesterase IV inhibitor SCH 351591. Toxicol. Pathol. 2010, 38(5):738-744.
60. Ye G., Fu G., Cui S., Zhao S., Bernaudo S., Bai Y., Ding Y., Zhang Y., Yang B.B., Peng C. MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance. J. Cell Sci. 2011, 124(Pt 3):359-368.
61. Zhang J., DeFelice A.F., Hanig J.P., Colastsky T. Biomarkers of endothelial cell activation serve as potential surrogate markers for drug-induced vascular injury. Toxicol. Pathol. 2010, 38(6):856-871.